MMJ Recs

MARCH 25, 2022

Image by msqrd2 on Pixabay : Looking for more information on patient drives in New York? The application process for a New York MMJ card typically involves the following steps: First, register with MMJRecs and create a patient login, providing some basic information and answering a short and simple questionnaire.

Patients 52

Patients Conditions Chronic Pain Dispensary 52

MMJ Recs

DECEMBER 20, 2023

The establishment of medical marijuana dispensaries in Virginia represents a progressive approach to healthcare, offering patients alternative treatment options for various medical conditions. Patients diagnosed with specific medical conditions are eligible to participate in the state’s medical cannabis program.

Dispensary 52

Dispensary Marijuana Strains Patients 52

The Cannigma

APRIL 12, 2023

Medical cannabis in Chile Chile legalized medical cannabis in 2015, allowing patients to access cannabis-based medicines with a prescription from a doctor. Patients can purchase cannabis-based medicines from authorized pharmacies, which are regulated by the Chilean Institute of Public Health.

Law 52

Law Decriminalization Recreational Epilepsy 52

NewsMunchies

MAY 8, 2023

In 2018, I was a Presenter at a Hillsborough County Bar Association event for a group of judges after Florida passed its limited medical marijuana bill. Florida’s medical marijuana law, passed in 2016, allows a qualified physician to authorize medical marijuana for patients for a variety of physical and mental conditions.

Law 81

Law Marijuana Conditions Epilepsy 81

Cannabis Law Report

OCTOBER 1, 2021

This year, the UK hosts the event in Glasgow, from the 1st to the 12th of November 2021. As stakeholders assemble for the summit, one group is aiming to highlight the overlooked environmental credentials of hemp by hosting a fringe event near the climate summit, at St Luke’s in Glasgow’s East End. What is not to love here?”.

Hemp 52

Hemp Epilepsy Events Conditions 52

Cannabis Law Report

AUGUST 17, 2021

reduction in 28-day seizure frequency relative to baseline in tuberous sclerosis complex (TSC) patients (n=23). reduction was observed in focal seizures (n=19), the most common seizure type in TSC patients. Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. RADNOR, Pa.–(BUSINESS

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

SpeedWeed

APRIL 2, 2021

The legacy of Charlotte Figi, the young Colorado girl whose struggle with epilepsy made CBD known worldwide, will be remembered next week with a benefit concert taking place in her honor. She had a rare form of epilepsy known as Dravet syndrome that caused dozens or even hundreds of seizures per day. She was the catalyst.

Events 52

Events Epilepsy Cannabinoids Treatment 52

Cannabis Law Report

DECEMBER 7, 2021

While cannabidiol was associated with a reduction in reported seizure events (RR?=?0.59, A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events. Adverse mental events were reported as well, however, more research should be performed to assess well this outcome. 1.69, 95% CI [1.20–2.36])

Safety 52

Safety Cannabinoids Events Data 52

CannaMD

SEPTEMBER 15, 2020

Current Florida medical marijuana patient? MORE DETAILS: On June 16, 2014, Florida became the 22nd state to legalize (at least partial) access to medical marijuana when Governor Rick Scott signed the Compassionate Medical Cannabis Act of 2014. Qualified patient. Thinking about getting your card? What about travel?

Law 126

Law Marijuana Patients Treatment 126

Veriheal

FEBRUARY 28, 2021

The last day of February, the 28th, or the 29th during a leap year is World Rare Disease Day and this day has been designated to help bring awareness to rare diseases as well as the impact they have on patients and their lives. This year, COVID-19 has dramatically impacted the way events are hosted.

Chronic Pain 52

Chronic Pain Events Therapy Treatment 52

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

MARCH 2, 2020

The UK government has eased import restrictions on medicinal cannabis, but has admitted it needs to do much more to improve access for patients. Licensed wholesalers will be able to import larger quantities of cannabis-based products, and hold supplies for future use by patients with prescriptions, according to a government release.

Medicine 59

Medicine Research and Development Clinical Trials Patients 59

SpeedWeed

MAY 5, 2021

Last week was eventful for cannabis reform in Texas, as the House of Representatives approved three legislative proposals, which would expand the state’s medical cannabis program, reduce penalties for concentrates and decriminalize possession. 1535 would also raise the THC limit in medical cannabis from 0.5%

Programs 52

Programs Chronic Pain Concentrates THC 52

SpeedWeed

MAY 4, 2021

Last week was eventful for cannabis reform in Texas, as the House of Representatives approved three legislative proposals, which would expand the state’s medical cannabis program, reduce penalties for concentrates and decriminalize possession. 1535 would also raise the THC limit in medical cannabis from 0.5%

Programs 52

Programs Chronic Pain Concentrates THC 52

Veriheal

OCTOBER 5, 2020

The program requires cannabis patients to have a licensed physician to certify that the individual would benefit from medical cannabis before they can register for it. The Hawaiian cannabis regulations also allow caregivers to take on the responsibility for managing the cannabis consumption and cultivation of the cannabis qualifying patient.

Edibles 52

Edibles Legalization Decriminalization Consumption 52

Puff Puff Post

MARCH 2, 2020

. · Export quotas allow for the manufacture of whole plant extract for international purposes to countries such as Peru, Uruguay, and Brazil, thereby accessing to a medical cannabis market of $1.4 ” Comments Juan Diego Alvarez, Khiron Vice-President of Regulatory Affairs. United States Disclaimer.

Extraction 52

Extraction THC Chronic Pain Cultivation 52

WeedAdvisor

MARCH 29, 2019

While CBD was already well-known to many medical users, those with only recreational access quickly fell into the hype. The most extensive research involved patients with severe – often untreatable – epilepsy. Much to the frustration of interested consumers, however, cupboards are bare – with no end in sight.

Oil 40

Oil CBD Research and Development Epilepsy 40

Cannabis Law Report

JANUARY 13, 2020

We are proud of the positive impact this medicine has already had on thousands of patients and believe that this past year provides a compelling foundation for continued success in 2020,” said Justin Gover, GW’s Chief Executive Officer. “Our fourth quarter and full year results for 2019 reflect an exceptional launch year for Epidiolex.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Puff Puff Post

MARCH 2, 2020

. · Export quotas allow for the manufacture of whole plant extract for international purposes to countries such as Peru, Uruguay, and Brazil, thereby accessing to a medical cannabis market of $1.4 ” Comments Juan Diego Alvarez, Khiron Vice-President of Regulatory Affairs. United States Disclaimer.

Extraction 40

Extraction THC Chronic Pain Cultivation 40

Cannabis Law Report

JANUARY 20, 2022

Eleusis pioneers the development of psychedelic drug candidates in the life sciences space, with the goal of transforming psychedelics into broadly accessible medicines. Medicines and Healthcare products Regulatory Agency’s Innovative Licensing and Access Pathway (“ILAP”), offering the potential to accelerate time to market.

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Law Report

JUNE 1, 2021

Steve Barbera to Vice President, Market Access. As we prepare for a potential world-class launch of Vicineum, I strongly believe that these leaders will not only bring diverse and invaluable expertise to our team but will also drive the Company to continue executing our mission to save and improve the lives of patients with cancer.”.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Sensi Seeds

JANUARY 7, 2019

As a long-time cannabis activist, entrepreneur and educator in a career spanning 40 years, today DeAngelo is the CEO of Harborside Health Center in Oakland, California, and a regular speaker at international industry events.

Education 94

Education Dispensary Media Cannabis 94

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Accessed July 25, 2021. Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

The Joint Blog

MARCH 9, 2022

Experts and specialists endorse them to treat extreme epilepsy and chemotherapy side effects. A vast scope study on the utilization of weed in the treatment of pediatric epilepsy observed that weed reduces seizures frequency by over half in 43% of the patients with Dravet syndrome. 1- Has Medicinal Properties.

Sleep 26

Sleep Treatment Conditions Epilepsy 26

Cannabis Law Report

JANUARY 5, 2022

This patent issuance is rewarding and timely as we launch our Phase 2 trial of MYMD-1 as a therapy for sarcopenia, frailty, and aging, which is currently recruiting patients,” said Chris Chapman, M.D., The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. 2 Goates et al.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Cannabis Law Report

NOVEMBER 16, 2021

The secondary measures will be the safety, tolerability, and pharmacokinetics in this population of patients. Because it can cross the blood-brain barrier and gain access to the central nervous system (CNS), MYMD-1 is also positioned to be a possible treatment for brain-related disorders. MyMD Contact: Robert Schatz. 646) 421-9523.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

OCTOBER 24, 2019

It will allow for regulated, supervised and limited access for our sick citizens especially those with cancer, HIV/ AIDS, glaucoma, and epilepsy. Politicians are listening closely to the public discussions and consultations being raised at Cannabis educational events about how to move forward. The oils can be legally imported.

Law 45

Law Medicine Decriminalization Oil 45

Puff Puff Post

NOVEMBER 30, 2018

With human patients benefiting from CBD’s therapeutic effects, pet owners want to know if their furry family members can also benefit from the herb. They want to push for access to CBD oil to treat sick animals. Our pets also develop chronic diseases and illnesses like cancer and epilepsy.

Pets 76

Pets Oil CBD Research and Development 76

The Cannigma

MAY 7, 2021

The Cannabis Enigma podcast is a co-production of The Cannigma and Americans for Safe Access. You’ve had this conversation in the US for over 20 years in some states so it’s not as if suddenly overnight, people have woken up to the discussion of cannabis and cannabis legalization and cannabis access. Music by Desca.

Supply Chain 120

Supply Chain Patients Access Hemp 120

CannaTech

JUNE 30, 2019

Changes to Israeli medical cannabis regulation by the Ministry of Health’s Medical Cannabis Association, locally known as Yakar, have left vulnerable patients with reduced access and increasing cots. Although changes were intended to reduce barriers to patient access, this has not been the case.

Patients 40

Patients Oil Epilepsy Strains 40

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. Barriers to facilitating both clinical and public health research regarding marijuana is detrimental to treating patients and the health of the public. Executive Summary. Relevant AAFP Policy. Call to Action.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Refractory paediatric epilepsy. The review, however, did not cover patient access to medicinal cannabis.

Research and Development 52

Research and Development Medicine Access Media 52

CannaTech

JUNE 30, 2019

These include changes to reduce barriers to patient access, specific licensing requirements for production, and expanding the number of access points approved of sale. The main goal of the reform is to ease bureaucratic hurdles for patients and to improve the quality and consistency of medical cannabis.

Patients 90

Patients Oil Epilepsy Strains 90

Cannabis Law Report

JANUARY 26, 2022

The designation is intended to accelerate the timeline for approval of innovative medicines for treatment of life-threatening conditions or those which present a significant patient or public health need. Our promising Phase 3 results lead us to apply for the Innovation Passport. Berra Yazar-Klosinski, Ph.D. Corine de Boer, M.D.,

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

CannaTech

FEBRUARY 3, 2020

CannaTech is an international event experience that unites cannabis professionals with breakout industry leaders for an unparalleled opportunity to learn, connect and define what’s next for the global cannabis industry. CBD-derived epilepsy drug Epidiolex is currently available in Swiss pharmacies as a prescription drug.

Events 52

Events Hemp CBD Medicine 52

Cannabis Law Report

JULY 15, 2022

“It’s very important from our perspective to ensure that the Australian patient gets medicine first. The first medicinal cannabis ‘mother’ plants are expected to be imported from Israel within a month, with manufacturing scheduled to begin within the first half of this year, to supply 5,000 Australian patients.

Medicine 52

Medicine Patients Media Supply Chain 52

Cannabis Law Report

OCTOBER 12, 2019

The scheme allows patients and doctors to access a legal domestic source of cannabis for medicinal use. The introduction of new legislation in Queensland (revoking the Public Health (Medicinal Cannabis) Act 2016 (Qld)) to simplify the process for patients and doctors to access medicinal cannabis. What’s next?

Medicine 40

Medicine Research and Development Cultivation Legislation 40